TWiV 1353: Phage bet-hedging and EBV antibodies

This Week in Virology by Vincent Racaniello

Aug 30, 202601:52:01Science & Medicine

TWiV explores how bacteriophages enable bet-hedge against bacterial immune defenses, and how transgenic mice engineered to produce human antibodies yielded potent anti-EBV candidates targeting gp350 and gp42, a promising...

Related Episodes

Continue listening to more episodes from This Week in Virology.

TWiV 1352: Clinical update with Dr. Daniel Griffin

Aug 29, 2026 - 48:56

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are disheartened by the suggested ch...

TWiV 1351: Ebola Virus Brains and Contagious Catfish Cancers

Aug 23, 2026 - 01:40:49

TWiV describes a human cerebral organoid model for Ebola virus persistence, and brown bullhead catfish me...

TWiV 1350: Clinical update with Dr. Daniel Griffin

Aug 22, 2026 - 01:00:49

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are perplexed by the state of global...

TWiV 1349: Smallpox and mummies

Aug 16, 2026 - 02:02:43

TWiV explains how liquid–liquid phase separation and a phage-encoded inhibitor cooperatively drive transc...

TWiV 1348: Clinical update with Dr. Daniel Griffin

Aug 15, 2026 - 54:40

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are troubled by the latest executive...

TWiV 1347: No Short Answers for Long COVID

Aug 9, 2026 - 01:47:26

TWiV explains research showing that Long COVID is associated with reactivation of numerous chronic viruse...

TWiV 1346: Clinical update with Dr. Daniel Griffin

Aug 8, 2026 - 54:29

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are distressed by Erica Schwartz' co...

TWiV 1345: Rocky Mountain Virology High

Aug 2, 2026 - 01:18:00

TWiV travels to Colorado State University in Ft. Collins, where he speaks with Angela Bosco-Lauth, Rebeka...